Professor Gavin Giovannoni MBBCh, PhD, FCP (S.A., Neurol.), FRCP, FRCPath
Gavin Giovannoni was appointed to the Chair of Neurology, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London and the Department of Neurology, Barts and The London NHS Trust in November 2006. In September 2008 he took over as the Neuroscience and Trauma Centre Lead in the Blizard Institute. Gavin did his undergraduate medical training at the University of the Witwatersrand, South Africa, where he graduated cum laude in 1987. He moved to the Institute of Neurology, University College London, Queen Square, London in 1993 after completing his specialist training in neurology in South Africa. After three years as a clinical research fellow, under Professor Ed Thompson, and then two years as the Scarfe Lecturer, working for Professor W. Ian McDonald, he was awarded a PhD in immunology from the University of London in 1998.
He was appointed as a Clinical Senior Lecturer, Royal Free and University College Medical School, in 1998 and moved back to Institute of Neurology, Queen Square in 1999. He was promoted to Reader in Neuroimmunology in 2004. His clinical interests are multiple sclerosis and other inflammatory disorders of the central nervous system. He is particularly interested in clinical issues related to optimising MS disease modifying therapies. His current research is focused on Epstein Barr virus as a possible cause of multiple sclerosis, defining the “multiple sclerosis endophenotype”, multiple sclerosis related neurodegeneration, multiple sclerosis biomarker discovery, multiple sclerosis clinical outcomes and immune tolerance strategies. His team focus on translational research and therefore have an active clinical trial programme.
Professor Emmanuelle L. Waubant
Dr. Emmanuelle L. Waubant is a neurologist who specializes in treating patients with multiple sclerosis (MS). She serves as director of the UCSF Regional Pediatric Multiple Sclerosis Center.
Waubant’s research focuses on new treatments for MS. She also studies environmental and genetic risk factors, including in children with the disease.
A native of France, Waubant earned her medical degree at the Lille University School of Medicine and completed a residency in neurology at Toulouse University Hospital, where she was chief resident as well as junior faculty for two years. She completed fellowships in neuroimmunology and clinical neuroimmunology at UCSF and then returned to her native country to head a clinical research center at the Pitié-Salpêtrière University Hospital in Paris. She joined the UCSF Multiple Sclerosis Center in 2001.
Waubant serves on the clinical care committee of the National Multiple Sclerosis Society’s local chapter and on the translational research review committee for the society’s national office. She chairs the clinical trial task force and serves on the steering committee of the International Pediatric Multiple Sclerosis Study Group.
A prominent contributor to scientific journals in her field, Waubant is one of two chief editors of Multiple Sclerosis and Related Disorders, and she is MS section editor for Annals of Clinical and Translational Neurology.
Professor William (Bill) Carroll MB BS, MD, FRACP FRCP(E)
Professor William Carroll is a Consultant Neurologist in the Department of Neurology and Neurophysiology at the Sir Charles Gairdner Hospital in Perth, Western Australia. He is also Chair of the Multiple Sclerosis Research Australia International Research Review Board, a previous chair of the Multiple Sclerosis Research Australia Management Council, a previous President of the Australian and New Zealand Association of Neurologists and President of the XV111 World Congress of Neurology 2005. He is currently the Asia Pacific editor of Multiple Sclerosis Journal, President of the World Federation of Neurology and foundation Vice President of the Pan Asian Committee for Research and Treatment of MS (PACTRIMS) and a member of the steering committee of the International Progressive MS Alliance (IPMSA). His principal research activity has been in demyelinating disease, both multiple sclerosis and of the biology of demyelination and remyelination in experimental optic neuropathy.